Evaluating Saving Lives at Birth: Cost-Effectiveness Analysis of BEMPU TempWatch

This report presents the cost-effectiveness analysis (CEA) of the BEMPU TempWatch — a Saving Lives at Birth (SL@B) funded innovation. The CEA quantifies the health and social impact of scaling BEMPU's TempWatch over the period 2018 to 2030 across fifteen states and fifteen tier-one cities in India. Cost data were collected directly from BEMPU, while impact estimates were obtained from models developed by Grand Challenges Canada (GCC) and reviewed by Duke University. Three incremental cost-effectiveness ratios (ICERs) were estimated at a 3% discount rate: (1) incremental costs per new beneficiary, (2) incremental costs per newborn life saved, and (3) incremental costs per year of life saved. By WHO-CHOICE criteria, an intervention is 'very cost-effective' if the ICER is less than the country's GDP per capita.